View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
CPSC | RIN: 3041-AC30 | Publication ID: Spring 2009 |
Title: Regulatory Options for Infant Pillows | |
Abstract: On July 13, 2006, the Commission voted 3-0 to grant a petition requesting that the Commission amend the ban on infant pillows under 16 CFR 1500.18(a)(16)(i). The staff prepared a draft advance notice of proposed rulemaking (ANPRM) concerning infant pillows to initiate a rulemaking proceeding under the Federal Hazardous Substances Act (FHSA) to identify the product and the risk of injury associated with infant pillows, summarize regulatory alternatives, and invite comments from the public. On September 27, 2006, the Commission issued the ANPRM. Staff reviewed public comments and prepared an options briefing package for Commission consideration. On February 1, 2008, the Commission voted 2-0 to exempt certain nursing pillows from the ban on infant pillows and to terminate rulemaking. On August 15, 2008, staff sent draft Federal Register Notices to the Commission. On August 25, 2008, the Commission voted 2-0 to issue a notice of proposed rulemaking (NPRM) which grants a proposed exemption for the Boston Billow Nursing Pillow and substantially similar nursing pillows. The Commission voted further to issue a notice terminating the currently pending rulemaking on infant cushions/pillows other than with respect to the Boston Billow Nursing Pillow and substantially similar nursing pillows. The NPRM and the Termination of Rulemaking were published in the Federal Register on September 3, 2008. Staff reviewed public comments on the NPRM and, on November 25, 2008, forwarded an options package to the Commission for consideration. On December 10, 2008, the Commission voted 2-0 to issue a final rule exempting the Boston Billows Nursing Pillow and substantially similar nursing pillows from classification as a banned hazardous substance. | |
Agency: Consumer Product Safety Commission(CPSC) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: 16 CFR 1500.18(a)(16)(i) | |
Legal Authority: 5 USC 553, Administrative Procedure Act 15 USC 1261, Federal Hazardous Substances Act |
Legal Deadline:
None |
||||||||||||||||||||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest. | |
RIN Data Printed in the FR: No | |
Agency Contact: Suad Wanna-Nakamura Ph.D Project Manager, Directorate for Health Sciences Consumer Product Safety Commission National Product Testing and Evaluation Center, 5 Research Place, Rockville, MD 20850 Phone:301 987-2550 Email: snakamura@cpsc.gov |